The Glenway Health Plan's pharmacy and therapeutics (P&T) committee conducted pharmacoeconomic research to measure both the clinical outcomes and costs of two new cholesterol-reducing drugs. Results were presented as a ratio showing the cost required to produce a 1 mcg/l decrease in cholesterol levels. The type of pharmacoeconomic research that Glenway conducted in this situation was most likely
Catalina
6 months agoSina
6 months agoBeckie
7 months agoJulio
7 months agoSol
7 months agoIzetta
7 months agoLettie
7 months agoAllene
7 months ago